The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Why do people in some parts of the country seem to be more at risk of certain diseases than others? Research is now pointing ...

GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...

A new study reveals that popular diabetes and weight loss medications like Ozempic and Wegovy may offer unexpected health ...

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

Nearly 70% of adults in Indiana are classified as overweight or obese, contributing to a broader health crisis in the United ...

Of late, there have been many questions about maintaining weight loss after using Ozempic (semaglutide) and whether the ...